Tag : full genome sequencing

Genomics

Genome Medical and Pierian Announce Collaboration

Business Wire
Partnership Combines Services and Tools to Help Providers and Health Organizations Build and Expand Internal Testing Capabilities Genome Medical, the leading telehealth provider of genetic...
Genomics

Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold

PR Newswire
Speakers will discuss how genomics drives more informed, inclusive, and proactive care Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today...
Genomics

Beam Therapeutics announces new preclinical data

GlobeNewswire
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced new preclinical data demonstrating the potential of the company’s...
Genomics

Fabric Genomics Expands Leadership Team in Precision Medicine

Business Wire
Former Chief Scientific Officer of GeneDx Sean Hofherr Joins as Chief Operating Officer and Clinical Director Fabric Genomics, Inc., a leader in AI-driven precision medicine,...
Genomics

GenScript Receives Best Cell & Gene Therapy Supplier Award

PR Newswire
GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK) and GenScriptProBio (a global one-stop CDMO from GenScript Group) receive 3 awards: Best Cell & Gene Therapy Supplier...
Genomics

SparingVision Raises €75 Million Series B

GlobeNewswire
SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases Proceeds to fund first-in-human trials of breakthrough gene therapy products, SPVN06 and SPVN20, and advance CRISPR-based genome editing portfolio...
Genomics

Debiopharm Co-leads a 10M USD Series A Round

PR Newswire
Debiopharm Innovation Fund strategically invests in Whitelab Genomics’ mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in...
Genomics

Reveal Genomics®️ Presents New Validation Data of Her2dx

PR Newswire
Presented during the ESMO Congress 2022, HER2DX®️ predicts the response of trastuzumab, pertuzumab and letrozole in patients with HER2+ HR+ breast cancer. This is the first...
Genomics

S2 Genomics Announces Distribution Agreement with Techtum Lab AB

Business Wire
Singulator™ 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. S2 Genomics, Inc. today announced that it has...